跳至主要内容
临床试验/JPRN-UMIN000008416
JPRN-UMIN000008416已完成未知

Randomized phase II study of neoadjuvant chemotherapy with or without letrozole for postmenopausal ER-positive/HER2-negative breast cancers - KBCOG 10

Kobe Breast Cancer Oncology Group0 个研究点目标入组 70 人开始时间: 2012年7月16日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
70

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
ot applicable 至 75years-old(—)
性别
Female

入选标准

  • 未提供

排除标准

  • 1) Inflammatory breast cancer 2) Bilateral breast cancers without DCIS or ICIS 3) With multiple cancers diagnosed with 5 years 4) With uncontrollable hypertension, angina pectoris, congestive heart failure 5) With severe complication including infection or uncontrolled diabetes mellitus 6) With viral hepatitis (HBs antigen- or HCV antibody-positive) 7) Patients treated with endocrine therapy 8) Infection or possible infection associated with clinical symptoms such as fever 9) With severe edema 10) With severe mental disorder 11) Cases who physician judged improper to entry this trial

研究者

发起方
Kobe Breast Cancer Oncology Group

相似试验

招募中
1 期
Bintrafusp alfa and Doxorubicin Hydrochloride in Treating Patients With Advanced Sarcoma.retroperitoneal sarcomasMedDRA version: 20.0Level: LLTClassification code 10039494Term: Sarcoma NOSSystem Organ Class: 100000004864MedDRA version: 20.0Level: LLTClassification code 10077289Term: Retroperitoneal sarcomaSystem Organ Class: 100000004864
EUCTR2021-001085-37-FRInstitut Bergonié66
已完成
2 期
Randomized Phase II Study of Neoadjuvant Chemotherapy and Trastuzumab (Herceptin) for Operable Breast Cancer with Overexpression of HER2Breast Cancer
JPRN-UMIN000000651Office for cordination of Herceptin trial100
招募中
2 期
Randomized phase II trial of neoadjuvant Chemotherapy with Gemcitabine and S-1 vs. without neoadjuvant chemotherapy in patients with resectable pancreatic cancerResectable pancreatic cancer
JPRN-UMIN000009822Chiba study group of adjuvant chemotherapy for pancreatic cancer74
招募中
不适用
Randomized phase II study of neoadjuvant chemoradiotherapy (S-1+radiation) for resectable pancreatic cancer with less than 180 degree portal vein abutmentresectable pancreatic cancer with less than 180 degree portal vein abutment
JPRN-UMIN000027633agoya University, Graduate School of Medicine56
进行中(未招募)
1 期
Study of chemotherapy and immunotherapy for patients with lung cancer bounded in the thorax and potentially resectableon-small cell lung cancerMedDRA version: 20.0 Level: LLT Classification code 10029514 Term: Non-small cell lung cancer NOS System Organ Class: 100000004864
EUCTR2018-004515-45-ESFundación GECP90
Randomized phase II study of neoadjuvant... | 临床试验